P1107 (DAIDS ID 11878): Cord Blood Transplantation using CCR5-Δ32 Donor Cells for the Treatment of HIV and Underlying Disease

Study Status Study Restriction

Enrolling

United States

What is P1107?

P1107 is multi-center observational study that will describe the outcomes of up to 25 HIV-infected participants from the US, ages 12 months and older, who undergo transplantation with CCR5Δ32 cord blood stem cells for treatment of cancer, hematopoietic disease, or other underlying disease.

Study Documents:

Study contacts:

Study Chair: Yvonne Bryson

Study Vice-Chair: Theodore Moore

Study Vice-Chair: Diane Wara

DAIDS Medical Officer: Renee Browning

NICHD Medical Officer: Rohan Hazra

Clinical Trials Specialist: Anne Coletti

Data Manager: Amanda Golner

Immunologist: Savita Pahwa

Investigator: Coleen Cunningham

Investigator: Lawrence Petz

Laboratory Data Manager (LDM): Laura Hovind

Laboratory Data Manager (LDM): Kaitley Wozer

Laboratory Specialist: Carolyn Yanavich

Laboratory Technologist: Patricia Anthony

Statistician: Meredith Warshaw

Virologist: Deborah Persaud

Westat Representative: Rita Patel

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.